Effectiveness and safety of fully oral modified shorter treatment regimen for multidrug-resistant tuberculosis in Georgia, 2019–2020

por Avaliani, Teona, Sereda, Yuliia, Davtyan, Hayk, Tukvadze, Nestani, Togonidze, Tamar, Kiria, Nana, Denisiuk, Olga, Gozalov, Ogtay, Ahmedov, Sevim, Hovhannesyan, Arax
Publicado 2021

Tuberculosis recovery in Georgia: implementing more by 24

por Kiria, Nana, Lomtadze, Nino, Solomonia, Nelly, Aspindzelashvili, Rusudan, Danelia, Maka, Gabisonia, Irakli, Janjgava, Marina, Khonelidze, Irma, Kipiani, Maia, Tukvadze, Nestani, Blumberg, Henry M, Kempker, Russell R, Furin, Jennifer, Avaliani, Zaza
Publicado 2022

Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines

por Gomez, Gabriela Beatriz, Siapka, Mariana, Conradie, Francesca, Ndjeka, Norbert, Garfin, Anna Marie Celina, Lomtadze, Nino, Avaliani, Zaza, Kiria, Nana, Malhotra, Shelly, Cook-Scalise, Sarah, Juneja, Sandeep, Everitt, Daniel, Spigelman, Melvin, Vassall, Anna
Publicado 2021

Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial

por Goodall, Ruth L, Meredith, Sarah K, Nunn, Andrew J, Bayissa, Adamu, Bhatnagar, Anuj K, Bronson, Gay, Chiang, Chen-Yuan, Conradie, Francesca, Gurumurthy, Meera, Kirenga, Bruce, Kiria, Nana, Meressa, Daniel, Moodliar, Ronelle, Narendran, Gopalan, Ngubane, Nosipho, Rassool, Mohammed, Sanders, Karen, Solanki, Rajesh, Squire, S Bertel, Torrea, Gabriela, Tsogt, Bazarragchaa, Tudor, Elena, Van Deun, Armand, Rusen, ID
Publicado 2022